InvestorsHub Logo

Jimmy Quick

11/20/19 11:45 AM

#129189 RE: stockforce #129008

This $191K was for just the Miami location alone from January 1, 2019 - June 30, 2019. This number should double for July 1, 2019 - December 31, 2019, as it will include the FPRX locations as well. At least this is my thoughts. So we should get roughly $380K for 3rd and 4th quarters and about $570K for the year.

247MarketAddict

11/21/19 7:01 AM

#129281 RE: stockforce #129008

Huge numbers for a 0.0x stock

stockforce

11/25/19 8:38 PM

#129723 RE: stockforce #129008

$RXMD Offers a Fresh Buying Opp in New Bull Trend - stockAlgorithms

https://www.tradingview.com/chart/RXMD/2hG5Wuyz-RXMD-Offers-a-Fresh-Buying-Opp-in-New-Bull-Trend/



Of course there will be some folks wanting to bank some profits here -- the stock was up as much as 135% this month alone, and is still up over 70% in November. But the technical action suggests a new, fresh bullish trend now underway, meaning that the opportunity here will be to take advantage of pullbacks.

The fundamental trend has changed as well, with the company recently reporting a breakout quarter in Q3 and guiding Q4 to the moon.


Progressive Care Reports October 2019 Performance: Q4 on Record Pace with Expanding Margins
Press Release | 11/19/2019

MIAMI, FL , Nov. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc . (OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to report another month of exceptional growth and expanding margins. October sales and prescriptions filled set a new record performance pace for Q4 results.

“The annualized pace we set in October equates to new records across the board as we continue to see broad-based top-line expansion on improving margins,” stated S. Parikh Mars, Progressive Care CEO . “Our $3.4 million in overall sales for October is an understatement because it leaves out the cash flows we took in during the month related to third-party billing activity. With all factors included, the number of gross billing would be closer to $4.2 million. And our 46k prescriptions filled puts Q4 on pace to handily surpass our breakout Q3 performance already. Execution continues to be tremendous, and I am very proud of our talented and dedicated team.”